BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20160139)

  • 1. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus.
    Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN
    Circulation; 2008 May; 117(21):2734-42. PubMed ID: 18490521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study).
    Morshedi-Meibodi A; Larson MG; Levy D; O'Donnell CJ; Vasan RS
    Am J Cardiol; 2002 Oct; 90(8):848-52. PubMed ID: 12372572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men.
    Adabag AS; Grandits GA; Prineas RJ; Crow RS; Bloomfield HE; Neaton JD;
    Am J Cardiol; 2008 May; 101(10):1437-43. PubMed ID: 18471455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of workload at the heart rate of 100 beats/min in predicting cardiovascular mortality in men aged 42, 48, 54, or 60 years at baseline.
    Savonen KP; Lakka TA; Laukkanen JA; Rauramaa TH; Salonen JT; Rauramaa R
    Am J Cardiol; 2007 Aug; 100(4):563-8. PubMed ID: 17697806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of graded exercise tolerance tests for prediction of cardiovascular mortality in old age: The Rancho Bernardo Study.
    Shin SY; Park JI; Park SK; Barrett-Connor E
    Int J Cardiol; 2015 Feb; 181():323-7. PubMed ID: 25544200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise cardiac power and the risk of coronary heart disease and cardiovascular mortality in men.
    Kurl S; Mäkikallio T; Jae SY; Ronkainen K; Laukkanen JA
    Ann Med; 2016 Dec; 48(8):625-630. PubMed ID: 27684365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study.
    Desai CS; Ning H; Lloyd-Jones DM
    Heart; 2012 Feb; 98(4):330-4. PubMed ID: 22139711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly upsloping ST-segment on exercise ECG: a marker of reduced coronary heart disease mortality risk.
    Hodnesdal C; Prestgaard E; Erikssen G; Gjesdal K; Kjeldsen SE; Liestol K; Skretteberg PT; Erikssen J; Bodegard J
    Eur J Prev Cardiol; 2013 Aug; 20(4):541-8. PubMed ID: 22492865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
    Oye-Somefun A; Kuk JL; Ardern CI
    BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
    Kodama S; Saito K; Tanaka S; Maki M; Yachi Y; Asumi M; Sugawara A; Totsuka K; Shimano H; Ohashi Y; Yamada N; Sone H
    JAMA; 2009 May; 301(19):2024-35. PubMed ID: 19454641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronotropic incompetence and mortality in middle-aged men with known or suspected coronary heart disease.
    Savonen KP; Kiviniemi V; Laukkanen JA; Lakka TA; Rauramaa TH; Salonen JT; Rauramaa R
    Eur Heart J; 2008 Aug; 29(15):1896-902. PubMed ID: 18556711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.
    Hoang K; Zhao Y; Gardin JM; Carnethon M; Mukamal K; Yanez D; Wong ND
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1007-1015. PubMed ID: 26319502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population.
    Hadaegh F; Hatami M; Mohebi R; Hasheminia M; Bozorgmanesh M; Sheikholeslami F; Azizi F
    Eur J Prev Cardiol; 2012 Dec; 19(6):1227-33. PubMed ID: 22013153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.